Versant Capital Management, Inc Myriad Genetics Inc Transaction History

Versant Capital Management, Inc

$454 Million
Q4 2024

A detailed history of Versant Capital Management, Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 1,384 shares of MYGN stock, worth $17,535. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,384

Previous 969 42.83%

Holding current value

$17,535

Previous $26,000 30.77%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 02, 2025	BUY	$13.17 - $27.03 $5,465 - $11,217	415 Added 42.83%	1,384 $18,000
Q2 2024 Jul 05, 2024	SELL	$17.98 - $25.47 $791 - $1,120	-44 Reduced 4.34%	969 $23,000
Q4 2023 Jan 08, 2024	SELL	$13.91 - $21.32 $8,276 - $12,685	-595 Reduced 37.0%	1,013 $19,000
Q3 2023 Oct 11, 2023	BUY	$15.99 - $23.22 $6,475 - $9,404	405 Added 33.67%	1,608 $25,000
Q2 2023 Jul 10, 2023	BUY	$17.56 - $23.76 $70 - $95	4 Added 0.33%	1,203 $27,000
Q1 2023 Apr 10, 2023	BUY	$15.26 - $23.75 $717 - $1,116	47 Added 4.08%	1,199 $27,000
Q3 2022 Dec 30, 2022	SELL	$18.21 - $27.88 $509 - $780	-28 Reduced 2.37%	1,152 $22,000
Q1 2022 Apr 29, 2022	SELL	$22.67 - $28.01 $2,221 - $2,744	-98 Reduced 7.67%	1,180 $30,000
Q4 2021 Jan 06, 2022	SELL	$24.13 - $32.63 $820 - $1,109	-34 Reduced 2.59%	1,278 $35,000
Q3 2021 Oct 29, 2021	BUY	$29.97 - $36.66 $479 - $586	16 Added 1.23%	1,312 $42,000
Q2 2021 Jul 22, 2021	BUY	$25.39 - $32.61 $228 - $293	9 Added 0.7%	1,296 $40,000
Q4 2020 Feb 08, 2021	SELL	$12.16 - $19.77 $1,702 - $2,767	-140 Reduced 9.81%	1,287 $25,000
Q3 2020 Nov 02, 2020	BUY	$11.25 - $14.75 $9,090 - $11,918	808 Added 130.53%	1,427 $18,000
Q2 2020 Jul 16, 2020	SELL	$10.69 - $16.49 $12,550 - $19,359	-1,174 Reduced 65.48%	619 $7,000
Q1 2020 Apr 17, 2020	BUY	$9.78 - $29.53 $10,083 - $30,445	1,031 Added 135.3%	1,793 $25,000
Q4 2019 Jan 28, 2020	SELL	$20.93 - $35.1 $816 - $1,368	-39 Reduced 4.87%	762 $20,000
Q3 2019 Oct 18, 2019	BUY	$22.08 - $47.08 $552 - $1,177	25 Added 3.22%	801 $22,000
Q2 2019 Jul 16, 2019	SELL	$22.67 - $35.0 $5,282 - $8,155	-233 Reduced 23.09%	776 $21,000
Q1 2019 Apr 23, 2019	BUY	$26.93 - $34.7 $26,283 - $33,867	976 Added 2957.58%	1,009 $33,000
Q1 2019 Apr 23, 2019	SELL	$26.93 - $34.7 $32,908 - $42,403	-1,222 Reduced 97.37%	33 $33,000
Q4 2018 Jan 29, 2019	SELL	$27.23 - $45.56 $1,198 - $2,004	-44 Reduced 3.39%	1,255 $36,000
Q3 2018 Oct 15, 2018	SELL	$37.57 - $50.34 $15,478 - $20,740	-412 Reduced 24.08%	1,299 $59,000
Q2 2018 Jul 06, 2018	SELL	$27.75 - $40.17 $5,300 - $7,672	-191 Reduced 10.04%	1,711 $63,000
Q1 2018 Apr 19, 2018	SELL	$28.83 - $41.01 $6,429 - $9,145	-223 Reduced 10.49%	1,902 $56,000
Q3 2017 Apr 23, 2018	BUY	$24.01 - $36.2 $8,643 - $13,032	360 Added 20.4%	2,125 $76,000
Q2 2017 Apr 23, 2018	BUY	N/A	650 Added 58.3%	1,765 $45,000
Q1 2017 Apr 23, 2018	BUY	N/A	1,115	1,115 $21,000

Others Institutions Holding MYGN

# of Institutions

248

Shares Held

91M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.02B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Account

Versant Capital Management, Inc Myriad Genetics Inc Transaction History